{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:28:06Z","timestamp":1789882086199,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,2,1]]},"DOI":"10.1038\/sj.bmt.1703373","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:14:42Z","timestamp":1031249682000},"page":"291-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia"],"prefix":"10.1038","volume":"29","author":[{"given":"S","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Powles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PJ","family":"Henslee-Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KY","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Treleaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Godder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"van Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Sirohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CR","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Meller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,3,4]]},"reference":[{"key":"BF1703373_CR1","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1182\/blood.V78.11.2814.2814","volume":"78","author":"CA Linker","year":"1991","unstructured":"Linker CA, Levitt LJ, O'Donnell M et al. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report Blood 1991 78: 2814 2822","journal-title":"Blood"},{"key":"BF1703373_CR2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood.V79.2.313.313","volume":"79","author":"PH Wiernik","year":"1992","unstructured":"Wiernik PH, Banks PL, Case DCJ et al. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia Blood 1992 79: 313 319","journal-title":"Blood"},{"key":"BF1703373_CR3","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood.V89.7.2311","volume":"89","author":"IM Hann","year":"1997","unstructured":"Hann IM, Stevens RF, Goldstone AH et al. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10) Blood 1997 89: 2311 2318","journal-title":"Blood"},{"key":"BF1703373_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/10428199909058483","volume":"34","author":"J Mehta","year":"1999","unstructured":"Mehta J, Powles R, Treleaven J et al. The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy Leuk Lymphoma 1999 34: 553 560","journal-title":"Leuk Lymphoma"},{"key":"BF1703373_CR5","first-page":"416","volume":"14","author":"MR Grever","year":"1987","unstructured":"Grever MR . Treatment of patients with acute nonlymphocytic leukemia not in remission Semin Oncol 1987 14: 416 424","journal-title":"Semin Oncol"},{"key":"BF1703373_CR6","first-page":"227a","volume":"90 (Suppl.\u20091)","author":"R Powles","year":"1997","unstructured":"Powles R, Treleaven J, Singhal S et al. Total therapy of acute myeloid leukemia: 7-year follow-up Blood 1997 90 (Suppl.\u20091): 227a","journal-title":"Blood"},{"key":"BF1703373_CR7","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/1097-0142(19850915)56:6<1374::AID-CNCR2820560626>3.0.CO;2-C","volume":"56","author":"AR Zander","year":"1985","unstructured":"Zander AR, Dicke KA, Keating M et al. Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy Cancer 1985 56: 1374 1379","journal-title":"Cancer"},{"key":"BF1703373_CR8","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1200\/JCO.1991.9.9.1570","volume":"9","author":"SJ Forman","year":"1991","unstructured":"Forman SJ, Schmidt GM, Nademanee AP et al. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia J Clin Oncol 1991 9: 1570 1574","journal-title":"J Clin Oncol"},{"key":"BF1703373_CR9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V80.4.1090.1090","volume":"80","author":"JC Biggs","year":"1992","unstructured":"Biggs JC, Horowitz MM, Gale RP et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy Blood 1992 80: 1090 1093","journal-title":"Blood"},{"key":"BF1703373_CR10","first-page":"415","volume":"14","author":"J Mehta","year":"1994","unstructured":"Mehta J, Powles R, Horton C et al. Bone marrow transplantation for primary refractory acute leukaemia Bone Marrow Transplant 1994 14: 415 418","journal-title":"Bone Marrow Transplant"},{"key":"BF1703373_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.bmt.1702800","volume":"27","author":"KY Chiang","year":"2001","unstructured":"Chiang KY, van Rhee F, Godder K et al. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia Bone Marrow Transplant 2001 27: 507 510","journal-title":"Bone Marrow Transplant"},{"key":"BF1703373_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/10428199309148199","volume":"10","author":"J Mehta","year":"1993","unstructured":"Mehta J . Graft-versus-leukemia reactions in clinical bone marrow transplantation Leuk Lymphoma 1993 10: 427 432","journal-title":"Leuk Lymphoma"},{"key":"BF1703373_CR13","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/blood.V89.10.3864","volume":"89","author":"PJ Henslee-Downey","year":"1997","unstructured":"Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allo-geneic marrow transplant Blood 1997 89: 3864 3872","journal-title":"Blood"},{"key":"BF1703373_CR14","first-page":"840a","volume":"96 (Suppl.\u20091)","author":"J Mehta","year":"2000","unstructured":"Mehta J, Singhal S, Chiang KY et al. Haploidentical BMT for acute leukemia: single-center experience of 220 patients Blood 2000 96 (Suppl.\u20091): 840a","journal-title":"Blood"},{"key":"BF1703373_CR15","first-page":"523","volume":"389","author":"C Lee","year":"1994","unstructured":"Lee C, Brouillette M, Lamb L et al. Use of a closed system for V\u03b1\u03b2-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation Prog Clin Biol Res 1994 389: 523 532","journal-title":"Prog Clin Biol Res"},{"key":"BF1703373_CR16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","volume":"355","author":"R Powles","year":"2000","unstructured":"Powles R, Mehta J, Kulkarni S et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial Lancet 2000 355: 1231 1237","journal-title":"Lancet"},{"key":"BF1703373_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/sj.bmt.1702542","volume":"26","author":"S Singhal","year":"2000","unstructured":"Singhal S, Powles R, Treleaven J et al. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2\u2009\u00d7\u2009106 CD34+ cells\/kg be considered the minimum threshold? Bone Marrow Transplant 2000 26: 489 496","journal-title":"Bone Marrow Transplant"},{"key":"BF1703373_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/00007890-199603150-00012","volume":"61","author":"PJ Henslee-Downey","year":"1996","unstructured":"Henslee-Downey PJ, Parrish RS, MacDonald JS et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant Transplantation 1996 61: 738 745","journal-title":"Transplantation"},{"key":"BF1703373_CR19","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","volume":"339","author":"F Aversa","year":"1998","unstructured":"Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186 1193","journal-title":"New Engl J Med"},{"key":"BF1703373_CR20","first-page":"392","volume-title":"The Clinical Practice of Stem Cell Transplantation","author":"PJ Henslee-Downey","year":"1998","unstructured":"Henslee-Downey PJ . Allogeneic related partially mismatched transplantation In: Barrett J, Treleaven JG (eds) The Clinical Practice of Stem Cell Transplantation Isis Medical Media: Oxford 1998 pp 392 417"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703373","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:36:20Z","timestamp":1648074980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,2,1]]}},"alternative-id":["BF1703373"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703373","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,1]]},"assertion":[{"value":"28 September 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}